全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Identifying Gaps in Real-World Management of Diabetes in Nigeria: A Subset Analysis of Cross-Sectional Wave-7 Data from the International Diabetes Management Practices Study

DOI: 10.4236/jdm.2022.124023, PP. 284-301

Keywords: Diabetes, Management Gaps, Nigeria

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background/Purpose: Poor glycemic control in Nigeria necessitates assessment and standardization of diabetes care. This study aimed to assess real-world management of people with type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) in Nigeria. Methods: This cross-sectional phase of the seventh wave of International Diabetes Management Practices Study, conducted between 22nd August and 30th September 2016, included adults with T1DM or T2DM during a two-week recruitment period. Results: Of 304 people with T2DM, 187 received oral glucose lowering drugs (OGLDs) only; 88 received OGLDs + insulin; 27 received insulin only. Metformin + sulfonylureas (128/187; 68.45%) and premix only (76/115; 66.09%) were the most used OGLD and insulin regimens respectively. Of 77 people with TIDM, all received insulin; six (7.79%) received OGLDs. Insulin initiation was noted around five years after diabetes diagnosis in T2DM (diabetes duration: 8.69 + 7.16 years; duration of insulin treatment: 3.17 ± 4.49 years). Proportion of people achieving glycemic targets (HbA1c < 7%: T2DM [66/202, 32.67%], T1DM [6/56, 10.71%]; clinical targets: T2DM [28/112, 25.00%], T1DM [14/74, 18.92%]; triple targets: T2DM [7/286, 2.45%], T1DM [3/64, 4.69%]) was low. Cost of medications/strips (92/144; 63.89%) and lack of experience in self-managing insulin (46/144; 31.94%) were main reasons for non-achievement of glycemic targets. Diabetes complications (253/372; 68.01%), hypoglycemia (symptomatic in the preceding three months: total = 97/373 [26.01%], T2DM = 61/300 [20.33%], T1DM = 36/73 [49.32%]; severe in the preceding 12 months: total = 32/368 [8.70%], T2DM = 17/298 [5.70%], T1DM = 15/70 [21.43%]) and hospitalizations (90/369; 24.39%) were common. Most participants (T2DM: 216/304 [71.05%]; T1DM: 62/76 [81.58%]) had a glucometer at home; few (T2DM: 44/113 [38.94%]; T1DM: 38/73 [52.05%]) self-managed both blood glucose and insulin. Conclusion: Early insulinization and subsidized healthcare can improve long-term diabetes outcomes in Nigeria.

References

[1]  Federation ID (2017) IDF Diabetes Atlas. Brussels.
http://www.diabetesatlas.org
[2]  Ogbera, A.O. and Ekpebegh, C. (2014) Diabetes Mellitus in Nigeria: The Past, Present and Future. World Journal of Diabetes, 5, 905-911.
https://doi.org/10.4239/wjd.v5.i6.905
[3]  Uloko, A.E., Musa, B.M., Ramalan, M.A., et al. (2018) Prevalence and Risk Factors for Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. Diabetes Therapy, 9, 1307-1316.
https://doi.org/10.1007/s13300-018-0441-1
[4]  Uloko, A.E., Ofoegbu, E.N., Chinenye, S., et al. (2012) Profile of Nigerians with Diabetes Mellitus—Diabcare Nigeria Study Group (2008): Results of a Multicenter Study. Indian Journal of Endocrinology and Metabolism, 16, 558-564.
https://doi.org/10.4103/2230-8210.98011
[5]  Organization WH. Nigeria (2016).
https://www.who.int/countries/nga/en
[6]  Federation ID (2000) IDF Diabetes Atlas 2000.
https://www.idf.org/e-library/epidemiology-research/diabetes-atlas/24-atlas-1st-edition.html
[7]  Federation ID (2015) IDF Diabetes Atlas 2015. 7th Edition.
[8]  Adeloye, D., Ige, J.O., Aderemi, A.V., et al. (2017) Estimating the Prevalence, Hospitalisation and Mortality from Type 2 Diabetes Mellitus in Nigeria: A Systematic Review and Meta-Analysis. BMJ Open, 7, e015424.
https://doi.org/10.1136/bmjopen-2016-015424
[9]  Guariguata, L., Whiting, D.R., Hambleton, I., et al. (2014) Global Estimates of Diabetes Prevalence for 2013 and Projections for 2035. Diabetes Research and Clinical Practice, 103, 137-149.
https://doi.org/10.1016/j.diabres.2013.11.002
[10]  Mbanya, J.C., Motala, A.A., Sobngwi, E., Assah, F.K. and Enoru, S.T. (2010) Diabetes in Sub-Saharan Africa. The Lancet (London, England), 375, 2254-2266.
https://doi.org/10.1016/S0140-6736(10)60550-8
[11]  Dahiru, T., Aliyu, A.A. and Shehu, A. (2016) A Review of Population-Based Studies on Diabetes Mellitus in Nigeria. Sub-Saharan African Journal of Medicine, 3, 59-64.
https://doi.org/10.4103/2384-5147.184351
[12]  Association ID (2013) IDF Diabetes Atlas. 6th Edition.
[13]  Ngwogu, K., Mba, I. and Ngwogu, A. (2012) Glycaemic Control amongst Diabetic Mellitus Patients in Umuahia Metroppolis, Abia State, Nigeria. International Journal of Basic, Applied and Innovative Research, 1, 98-104.
[14]  Adibe, M.O., Anosike, C., Nduka, S.O. and Isah, A. (2018) Evaluation of Health Status of Type 2 Diabetes Outpatients Receiving Care in a Tertiary Hospital in Nigeria. Pharmacoecon Open, 2, 337-345.
https://doi.org/10.1007/s41669-017-0056-x
[15]  Fasanmade, O.A. and Dagogo-Jack, S. (2015) Diabetes Care in Nigeria. Annals of Global Health, 81, 821-829.
https://doi.org/10.1016/j.aogh.2015.12.012
[16]  Oguejiofor, O. (2014) Diabetes in Nigeria: Impact, Challenges, Future Directions. Endocrinology & Metabolic Syndrome, 3, Article No. 130.
https://doi.org/10.4172/2161-1017.1000130
[17]  Davies, M.J., D’Alessio, D.A., Fradkin, J., et al. (2018) Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 41, 2669-2701.
https://doi.org/10.2337/dci18-0033
[18]  Inzucchi, S.E., Bergenstal, R.M., Buse, J.B., et al. (2015) Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 38, 140-149.
https://doi.org/10.2337/dc14-2441
[19]  Ogu, R., Chinenye, S. and Korubo, I. (2015) Diabetes Advocacy and Care in Nigeria: A Review Sunday Chinenye, Rosemary Ogu, Ibitrokoemi Korubo. The Nigeria Health Journal, 15, Article No. 145.
[20]  Okoro, E.O., Adejumo, A.O. and Oyejola, B.A. (2002) Diabetic Care in Nigeria: Report of a Self-Audit. Journal of Diabetes and Its Complications, 16, 159-164.
https://doi.org/10.1016/S1056-8727(01)00145-3
[21]  World Medical Association (2013) World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. JAMA, 310, 2191-2194.
https://doi.org/10.1001/jama.2013.281053
[22]  Goodyear, L.J. (2008) The Exercise Pill—Too Good to Be True? New England Journal of Medicine, 359, 1842-1844.
https://doi.org/10.1056/NEJMcibr0806723
[23]  Abioye-Kuteyi, E.A., Ojofeitimi, E.O., Ijadunola, K.T. and Fasanu, A.O. (2005) Assessment of Dietary Knowledge, Practices and Control in Type 2 Diabetes in a Nigerian Teaching Hospital. Nigerian Journal of Medicine: Journal of the National Association of Resident Doctors of Nigeria, 14, 58-64.
https://doi.org/10.4314/njm.v14i1.37137
[24]  Ntui, I., Udoh, A.E., Esiere, K.-U.S., Essien, O. and Egbe, E.R. (2006) The Pattern of Dietary Habits and Glycemic Control of Diabetics in Eastern Nigeria. Pakistan Journal of Nutrition, 5, 43-45.
https://doi.org/10.3923/pjn.2006.43.45
[25]  Ezeani Ignatius, U., Onyeonoro, U.U., Ugwu, T.E., Chuku, A. and Aihanuwa, E. (2017) Challenges with Insulin Use among Patients with Type 2 Diabetes Mellitus: Focus on a Tertiary Healthcare Setting in South-East Nigeria. Current Diabetes Reviews, 13, 175-181.
https://doi.org/10.2174/1573399812666151016110355
[26]  Owens, D.R. (2013) Clinical Evidence for the Earlier Initiation of Insulin Therapy in Type 2 Diabetes. Diabetes Technology & Therapeutics, 15, 776-785.
https://doi.org/10.1089/dia.2013.0081
[27]  Ufuoma, C., Godwin, Y.D., Kester, A.D. and Ngozi, J.C. (2016) Determinants of Glycemic Control among Persons with Type 2 Diabetes Mellitus in Niger Delta. Sahel Medical Journal, 19, Article No. 190.
https://doi.org/10.4103/1118-8561.196361
[28]  Stephani, V., Opoku, D. and Beran, D. (2018) Self-Management of Diabetes in Sub-Saharan Africa: A Systematic Review. BMC Public Health, 18, Article No. 1148.
https://doi.org/10.1186/s12889-018-6050-0
[29]  Mbanya, J.C., Naidoo, P., Kolawole, B.A., Tsymbal, E., McMaster, A., Karamchand, S., et al. (2020) Management of Adult Patients with Type 1 Diabetes Mellitus in Africa: A Post-Hoc Cohort Analysis of 12 African Countries Participating in the International Diabetes Management Practices Study (Wave 7). Medicine (Baltimore), 99, e20553.
https://doi.org/10.1097/MD.0000000000020553
[30]  Olamoyegun, M.A., Akinlade, A.T. and Ala, O.A. (2018) Audit of Insulin Prescription Patterns and Associated Burden among Diabetics in a Tertiary Health Institution in Nigeria. African Health Sciences, 18, 852-864.
https://doi.org/10.4314/ahs.v18i4.3
[31]  Awodele, O. and Osuolale, J.A. (2015) Medication Adherence in Type 2 Diabetes Patients: Study of Patients in Alimosho General Hospital, Igando, Lagos, Nigeria. African Health Sciences, 15, 513-522.
https://doi.org/10.4314/ahs.v15i2.26

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133